As TRAIL is known to cause apoptosis in several cancer cells [30,31,32], it can be used to suppress ASC-induced tumorigenesis; moreover, treatment with IFN-β has also been reported to suppress cancer in breast [19] and hepatic [18] cancer cells. Here, TNFSF10 is linked to cancer.